Annual Working Capital
$277.64 M
+$72.86 M+35.58%
December 31, 2023
Summary
- As of February 26, 2025, FDMT annual working capital is $277.64 million, with the most recent change of +$72.86 million (+35.58%) on December 31, 2023.
- During the last 3 years, FDMT annual working capital has risen by +$11.72 million (+4.41%).
- FDMT annual working capital is now at all-time high.
Performance
FDMT Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$481.29 M
-$51.94 M-9.74%
September 30, 2024
Summary
- As of February 26, 2025, FDMT quarterly working capital is $481.29 million, with the most recent change of -$51.94 million (-9.74%) on September 30, 2024.
- Over the past year, FDMT quarterly working capital has increased by +$171.21 million (+55.22%).
- FDMT quarterly working capital is now -9.74% below its all-time high of $533.23 million, reached on June 30, 2024.
Performance
FDMT Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
FDMT Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +35.6% | +55.2% |
| 3 y3 years | +4.4% | +55.2% |
| 5 y5 years | +222.8% | +55.2% |
FDMT Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +35.6% | -9.7% | +145.9% |
| 5 y | 5-year | at high | +601.9% | -9.7% | +1116.8% |
| alltime | all time | at high | +1393.4% | -9.7% | +1116.8% |
4D Molecular Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $481.29 M(-9.7%) |
| Jun 2024 | - | $533.23 M(+2.7%) |
| Mar 2024 | - | $519.19 M(+87.0%) |
| Dec 2023 | $277.64 M(+35.6%) | $277.64 M(-10.5%) |
| Sep 2023 | - | $310.08 M(+2.0%) |
| Jun 2023 | - | $304.03 M(+55.3%) |
| Mar 2023 | - | $195.76 M(-4.4%) |
| Dec 2022 | $204.78 M | $204.78 M(-6.5%) |
| Sep 2022 | - | $218.91 M(-5.7%) |
| Jun 2022 | - | $232.19 M(+0.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $230.96 M(-3.7%) |
| Dec 2021 | $239.94 M(-9.8%) | $239.94 M(+55.4%) |
| Sep 2021 | - | $154.36 M(-35.4%) |
| Jun 2021 | - | $238.88 M(-4.7%) |
| Mar 2021 | - | $250.59 M(-5.8%) |
| Dec 2020 | $265.91 M(+572.3%) | $265.91 M(+239.8%) |
| Sep 2020 | - | $78.26 M(+97.9%) |
| Dec 2019 | $39.55 M(-54.0%) | $39.55 M(-40.8%) |
| Jun 2019 | - | $66.84 M(-22.3%) |
| Dec 2018 | $86.01 M(+362.7%) | $86.01 M |
| Dec 2017 | $18.59 M | - |
FAQ
- What is 4D Molecular Therapeutics annual working capital?
- What is the all time high annual working capital for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics annual working capital year-on-year change?
- What is 4D Molecular Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics quarterly working capital year-on-year change?
What is 4D Molecular Therapeutics annual working capital?
The current annual working capital of FDMT is $277.64 M
What is the all time high annual working capital for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high annual working capital is $277.64 M
What is 4D Molecular Therapeutics annual working capital year-on-year change?
Over the past year, FDMT annual working capital has changed by +$72.86 M (+35.58%)
What is 4D Molecular Therapeutics quarterly working capital?
The current quarterly working capital of FDMT is $481.29 M
What is the all time high quarterly working capital for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high quarterly working capital is $533.23 M
What is 4D Molecular Therapeutics quarterly working capital year-on-year change?
Over the past year, FDMT quarterly working capital has changed by +$171.21 M (+55.22%)